Madrigal Pharmaceuticals, Inc. MDGL Inventories
Inventories at other companies
Other financials
Where this comes from
Reported directly by Madrigal Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:InventoryNet.
The official record: Madrigal Pharmaceuticals, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Madrigal Pharmaceuticals, Inc.'s inventories.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Madrigal Pharmaceuticals, Inc.'s inventories?
- Madrigal Pharmaceuticals, Inc. (MDGL) reported inventories of $112.07M in Q1 2026.
- How has Madrigal Pharmaceuticals, Inc.'s inventories changed year-over-year?
- Madrigal Pharmaceuticals, Inc.'s inventories increased by 102.9% year-over-year, from $55.24M to $112.07M.
- What does inventories mean?
- The total value of all goods and materials the company currently holds for production or sale.
- How do you interpret inventories?
- An increase may signal preparation for a product launch or supply chain buildup, while a decrease could indicate strong sales or inventory management efficiency.
- How does inventories compare across companies?
- Levels fluctuate based on the company's proximity to commercial launch and regulatory approval timelines.